More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].
DuMontier C, La J, Bihn J, Corrigan J, Yildirim C, Dharne M, Hassan H, Yellapragada S, Abel GA, Gaziano JM, Do NV, Brophy M, Kim DH, Munshi NC, Fillmore NR, Driver JA.
DuMontier C, et al. Among authors: hassan h.
Blood Adv. 2023 Oct 24;7(20):6275-6284. doi: 10.1182/bloodadvances.2023011019.
Blood Adv. 2023.
PMID: 37582048
Free PMC article.
Clinical Trial.